Olink Holding AB operates as a holding company. The Company, through its subsidiaries, focuses on discovery and development protein biomarker based on a flexible and scalable technology platform for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Olink Holding serves customers worldwide.